gastrointestinal diseases and disorders

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

1.409 documents for gastrointestinal diseases and disorders

- Dollars and Sense: How a Small Brand Can Outsmart a Crowd
For Santarus, which focuses on acquiring, developing and commercializing products for the prevention and treatment of gastrointestinal diseases and disorders, big-brand budgets are no longer necessary to compete against big-name brands. The Internet has leveled the playing field. Having defined the objectives and measurement criteria for a proton pump inhibitor Zegerid, a strategic decision was made to focus on three online channels: organic search, paid search and online advertising. In leveraging the power of paid search for Zegerid, the objective was to capture qualified traffic, drive on-site conversions, and generate trial as measured by coupon prints and redemptions. The results proved highly successful. Due to banner advertising, overall awareness of Zegerid increased by 90% amon...
- Medical Marketing and Media
- September 02, 2009
- Presumptive Service Connection for Diseases Associated with Persian Gulf War Service:
... Gulf War Service: Functional Gastrointestinal Disorders. AGENCY: Department of Veterans Affairs....
- FR, November 17, 2010
- Proposed rules
- Veterans Affairs Department
- Synergy Pharmaceuticals Appoints Dr. Laura Barrow as Vice President of Clinical Operations.
... developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today the a...
- Business Wire
- March 22, 2011

- Synergy Pharmaceuticals Initiates Dosing of Patients in Phase II/III Trial of Plecanatide in Chronic Constipation.
... developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initi...
- Business Wire
- October 24, 2011
- Zacks Bull and Bear of the Day Highlights: Tiffany & Co., Sunoco, Inc., Santarus Inc., Merck and GlaxoSmithKline.
... of the risk of several upper gastrointestinal diseases and disorders. It is already marketed as ...
- Business Wire
- April 07, 2010
- Synergy Pharmaceuticals Raises $5.64 Million in Financing.
... developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that ...
- Business Wire
- November 15, 2011
- R&D Council to Honor Industry and Academia Inventors at the 31st Thomas Alva Edison Patent Awards Ceremony.
..., prevention and management of gastrointestinal diseases and disorders such as irritable bowel syn...
- Business Wire
- October 08, 2010
- Synergy Pharmaceuticals and Fox Chase Cancer Center Presentation at 2011 ACG Meeting Highlights Potential of GC-C Agonists to Delay Progression of Colitis into Colon Cancer.
... developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that ...
- Business Wire
- October 31, 2011
- Pediatric Clinical Trials Workshop: Unmet Needs, Trial Designs and Clinically Meaningful Safety and Effectiveness Outcomes
... clinical trials involving pediatric diseases and patients. Information from this public worksho... into the use of devices to treat disorders and diseases that affect pediatric patients. II. W...Abdominal disorders and gastrointestinal (GI) diseases,. Neurologic disorders and condition...
- FR, September 14, 2009
- Notices
- Food and Drug Administration
- Synergy Pharmaceuticals Announces New Clinical Development Plan for Plecanatide.
... developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that ...
- Business Wire
- January 07, 2011